What Researchers Did
Researchers presented a case report detailing the diagnosis and multimodal treatment of refractory postsurgical pyoderma gangrenosum in a 41-year-old woman.
What They Found
A 41-year-old woman developed progressive deep chest wall ulcerations after multiple surgeries, including bilateral reduction mammoplasty and mastectomy, which were diagnosed as pyoderma gangrenosum. She failed numerous treatments, including various immunomodulatory agents, surgical wound closure, and negative pressure wound therapy. Ultimately, a multimodal approach involving adalimumab, mycophenolate mofetil, prednisone, and hyperbaric oxygen therapy led to progressive healing.
What This Means for Canadian Patients
Canadian patients suffering from severe, difficult-to-treat pyoderma gangrenosum might benefit from a collaborative, multimodal treatment approach. This could involve a combination of immunomodulatory drugs and other therapies like hyperbaric oxygen, especially when standard treatments fail.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from outside Canada.
Study Limitations
As a single case report, the findings may not be generalizable to a broader patient population with pyoderma gangrenosum.